QR Kod

FOLFIRINOX for advanced pancreatic adenocarcinoma in Brazil: a single-institution experience

Objective: Data is lacking about FOLFIRINOX use for advanced pancreatic ductal adenocarcinoma in emerging countries. The objective of this study was to report outcomes of efficacy and safety in the setting of a South American institution.

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: José Mauricio Mota, Andre Henares Campos Silva, Andre Silva Franco, Aley Talans, Felipe Ribeiro-Ferreira, Tiago Biachi de Castria, Jorge Sabbaga, Paulo M. Hoff
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Thieme Revinter Publicações Ltda. 2018-01-01
Seri Bilgileri:Brazilian Journal of Oncology
Konular:
Online Erişim:http://www.thieme-connect.de/DOI/DOI?10.26790/BJO20181447A197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!